These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11264190)

  • 1. Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells.
    Guzman ML; Upchurch D; Grimes B; Howard DS; Rizzieri DA; Luger SM; Phillips GL; Jordan CT
    Blood; 2001 Apr; 97(7):2177-9. PubMed ID: 11264190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.
    Kawagoe H; Humphries RK; Blair A; Sutherland HJ; Hogge DE
    Leukemia; 1999 May; 13(5):687-98. PubMed ID: 10374871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia.
    Feuring-Buske M; Hogge DE
    Blood; 2001 Jun; 97(12):3882-9. PubMed ID: 11389030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors.
    Costello R; Mallet F; Chambost H; Sainty D; Arnoulet C; Gastaut JA; Olive D
    Leukemia; 1999 Oct; 13(10):1513-8. PubMed ID: 10516751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Flt3 and c-kit during growth and maturation of human CD34+CD38- cells.
    Xiao M; Oppenlander BK; Plunkett JM; Dooley DC
    Exp Hematol; 1999 May; 27(5):916-27. PubMed ID: 10340408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit(+)CD33(-)CD38(-) fraction of umbilical cord CD34(+) cells.
    Liu H; Verfaillie CM
    Exp Hematol; 2002 Jun; 30(6):582-9. PubMed ID: 12063025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional expression of Fas (CD95) in acute myeloid leukemia cells in the context of CD34 and CD38 expression: possible correlation with sensitivity to chemotherapy.
    Iijima N; Miyamura K; Itou T; Tanimoto M; Sobue R; Saito H
    Blood; 1997 Dec; 90(12):4901-9. PubMed ID: 9389707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of leukemic cells in the CD34(+)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia.
    George AA; Franklin J; Kerkof K; Shah AJ; Price M; Tsark E; Bockstoce D; Yao D; Hart N; Carcich S; Parkman R; Crooks GM; Weinberg K
    Blood; 2001 Jun; 97(12):3925-30. PubMed ID: 11389036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia.
    Mehrotra B; George TI; Kavanau K; Avet-Loiseau H; Moore D; Willman CL; Slovak ML; Atwater S; Head DR; Pallavicini MG
    Blood; 1995 Aug; 86(3):1139-47. PubMed ID: 7542497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia.
    Cobaleda C; Gutiérrez-Cianca N; Pérez-Losada J; Flores T; García-Sanz R; González M; Sánchez-García I
    Blood; 2000 Feb; 95(3):1007-13. PubMed ID: 10648416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia.
    Maguer-Satta V; Petzer AL; Eaves AC; Eaves CJ
    Blood; 1996 Sep; 88(5):1796-804. PubMed ID: 8781437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
    Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
    Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3.
    Holyoake TL; Jiang X; Jorgensen HG; Graham S; Alcorn MJ; Laird C; Eaves AC; Eaves CJ
    Blood; 2001 Feb; 97(3):720-8. PubMed ID: 11157490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal chromosomal abnormalities in the stem cell compartment of patients with acute myeloid leukemia in morphological complete remission.
    Feuring-Buske M; Haase D; Buske C; Hiddemann W; Wörmann B
    Leukemia; 1999 Mar; 13(3):386-92. PubMed ID: 10086729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia.
    Turhan AG; Lemoine FM; Debert C; Bonnet ML; Baillou C; Picard F; Macintyre EA; Varet B
    Blood; 1995 Apr; 85(8):2154-61. PubMed ID: 7536493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. During ontogeny primitive (CD34(+)CD38(-)) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts.
    Oh IH; Lau A; Eaves CJ
    Blood; 2000 Dec; 96(13):4160-8. PubMed ID: 11110687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased CD38 expression is associated with favorable prognosis in adult acute leukemia.
    Keyhani A; Huh YO; Jendiroba D; Pagliaro L; Cortez J; Pierce S; Pearlman M; Estey E; Kantarjian H; Freireich EJ
    Leuk Res; 2000 Feb; 24(2):153-9. PubMed ID: 10654451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of gene expression in highly purified hematopoietic cells using real-time reverse transcriptase polymerase chain reaction.
    Raaijmakers MH; van Emst L; de Witte T; Mensink E; Raymakers RA
    Exp Hematol; 2002 May; 30(5):481-7. PubMed ID: 12031655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of CD38 antigen on CD34+CD38+ cells during short-term culture.
    von Laer D; Corovic A; Vogt B; Fehse B; Roscher S; Rimek A; Baum C; Ostertag W
    Leukemia; 2000 May; 14(5):947-8. PubMed ID: 10803533
    [No Abstract]   [Full Text] [Related]  

  • 20. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.
    Erickson PF; Dessev G; Lasher RS; Philips G; Robinson M; Drabkin HA
    Blood; 1996 Sep; 88(5):1813-23. PubMed ID: 8781439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.